Methoxyamine Completed Phase 1 Trials for Intraocular Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Refractory Multiple Myeloma / Recurrent Adult Immunoblastic Large Cell Lymphoma / Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Hepatosplenic T-Cell Lymphoma / Splenic Marginal Zone Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Peripheral T-Cell Lymphoma (PTCL) / Relapsing Chronic Myelogenous Leukemia / Waldenström's Macroglobulinemia (WM) / Recurrent Marginal Zone Lymphoma / Chronic Lymphocytic Leukemia (CLL) - Refractory / Stage III Chronic Lymphocytic Leukemia / Cutaneous B-Cell Non-Hodgkin Lymphoma / Testicular Lymphoma / Recurrent Adult Burkitt Lymphoma / Recurrent Small Lymphocytic Lymphoma / Angioimmunoblastic T-Cell Lymphoma / Small Intestine Lymphoma / Recurrent Grade 3 Follicular Lymphoma / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma / Recurrent Adult T-Cell Leukemia/Lymphoma / Recurrent Mycosis Fungoides/Sezary Syndrome / Adult Nasal Type Extranodal NK/T-Cell Lymphoma / Recurrent Adult Hodgkin's Lymphoma / Anaplastic Large Cell Lymphoma / Nodal marginal zone B-cell lymphomas / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01658319Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies